STOCK TITAN

Moolec Science Announces Effectiveness of Reverse Stock Split

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Moolec Science (NASDAQ:MLEC) has announced the implementation of a 1-for-10 reverse stock split, effective May 14, 2025, at 8:30 AM Eastern Time. The consolidation will reduce the company's outstanding shares from approximately 40 million to 4 million shares, with no change to the par value per share. The stock will continue trading on NASDAQ under the symbol "MLEC" with a new CUSIP code (L64875 120), while warrants will maintain their "MLECW" symbol. Shareholders are not required to take any action, as positions will be automatically adjusted. The reverse split follows resolutions passed at the extraordinary general meeting and board meeting on April 22, 2025.
Moolec Science (NASDAQ:MLEC) ha annunciato l'implementazione di un raggruppamento azionario inverso 1 per 10, efficace dal 14 maggio 2025 alle 8:30 ora Eastern. La consolidazione ridurrà le azioni in circolazione da circa 40 milioni a 4 milioni, senza modificare il valore nominale per azione. Le azioni continueranno a essere negoziate sul NASDAQ con il simbolo "MLEC" e un nuovo codice CUSIP (L64875 120), mentre i warrant manterranno il simbolo "MLECW". Gli azionisti non devono intraprendere alcuna azione, poiché le posizioni saranno adeguate automaticamente. Il raggruppamento segue le delibere approvate durante l'assemblea straordinaria e la riunione del consiglio del 22 aprile 2025.
Moolec Science (NASDAQ:MLEC) ha anunciado la implementación de una consolidación inversa de acciones 1 por 10, efectiva a partir del 14 de mayo de 2025 a las 8:30 AM hora del Este. La consolidación reducirá las acciones en circulación de aproximadamente 40 millones a 4 millones, sin cambiar el valor nominal por acción. Las acciones seguirán cotizando en NASDAQ bajo el símbolo "MLEC" con un nuevo código CUSIP (L64875 120), mientras que los warrants mantendrán el símbolo "MLECW". Los accionistas no necesitan realizar ninguna acción, ya que las posiciones se ajustarán automáticamente. La consolidación se produce tras las resoluciones aprobadas en la junta general extraordinaria y la reunión del consejo el 22 de abril de 2025.
Moolec Science(NASDAQ:MLEC)는 2025년 5월 14일 오전 8시 30분(동부 시간)부터 1대 10 역병합을 시행한다고 발표했습니다. 이번 병합으로 회사의 발행 주식 수가 약 4천만 주에서 400만 주로 감소하며, 주당 액면가는 변경되지 않습니다. 주식은 NASDAQ에서 "MLEC" 심볼로 계속 거래되며, 새로운 CUSIP 코드(L64875 120)가 부여됩니다. 워런트는 "MLECW" 심볼을 유지합니다. 주주들은 별도의 조치를 취할 필요 없으며, 보유 주식 수가 자동으로 조정됩니다. 이번 역병합은 2025년 4월 22일에 열린 임시 주주총회와 이사회 결의에 따른 것입니다.
Moolec Science (NASDAQ:MLEC) a annoncé la mise en œuvre d'un regroupement d'actions inversé au ratio de 1 pour 10, effectif à partir du 14 mai 2025 à 8h30 heure de l'Est. Cette consolidation réduira le nombre d'actions en circulation d'environ 40 millions à 4 millions, sans modification de la valeur nominale par action. Les actions continueront d'être négociées sur le NASDAQ sous le symbole "MLEC" avec un nouveau code CUSIP (L64875 120), tandis que les warrants conserveront leur symbole "MLECW". Les actionnaires n'ont aucune démarche à effectuer, leurs positions seront ajustées automatiquement. Ce regroupement fait suite aux résolutions adoptées lors de l'assemblée générale extraordinaire et du conseil d'administration du 22 avril 2025.
Moolec Science (NASDAQ:MLEC) hat die Durchführung eines 1-zu-10 Reverse Stock Splits angekündigt, der ab dem 14. Mai 2025 um 8:30 Uhr Eastern Time wirksam wird. Die Konsolidierung wird die ausstehenden Aktien von etwa 40 Millionen auf 4 Millionen reduzieren, ohne den Nennwert je Aktie zu ändern. Die Aktie wird weiterhin unter dem Symbol "MLEC" an der NASDAQ gehandelt, jedoch mit einem neuen CUSIP-Code (L64875 120), während die Warrants das Symbol "MLECW" behalten. Aktionäre müssen keine Maßnahmen ergreifen, da die Positionen automatisch angepasst werden. Der Reverse Split folgt den Beschlüssen der außerordentlichen Hauptversammlung und der Vorstandssitzung vom 22. April 2025.
Positive
  • None.
Negative
  • Reverse stock split typically indicates share price concerns and potential delisting risk

Insights

Moolec's 1-for-10 reverse split aims to maintain Nasdaq compliance but signals potential concerns about share price performance.

Moolec Science's announcement of a one-for-ten reverse stock split represents a significant capital structure change that will reduce their outstanding shares from approximately 40 million to 4 million. While the company hasn't explicitly stated the rationale, reverse splits are typically implemented when share prices fall below exchange listing requirements (often $1 for Nasdaq). This maneuver mathematically increases the per-share price by consolidating shares without changing the company's underlying market capitalization.

The timing is particularly important as the split becomes effective May 14, 2025. Shareholders won't need to take action as positions will automatically adjust, though the psychological impact on market perception can be significant. The company will continue trading under the same ticker (MLEC) but with a new CUSIP identifier (L64875 120), while their warrants remain under MLECW with unchanged identifiers.

Historically, reverse splits send mixed signals to the market. While technically neutral in valuation terms, they often indicate underlying financial challenges, as companies typically prefer forward splits when performing well. Smaller food tech companies like Moolec face particular scrutiny when implementing reverse splits, as investors may interpret this as a defensive move to maintain listing requirements rather than addressing fundamental business growth. This restructuring occurs during a challenging period for alternative protein companies, many of which have struggled with commercialization timelines and profitability paths.

LUXEMBOURG, LU / ACCESS Newswire / May 12, 2025 / Moolec Science SA (NASDAQ:MLEC; the "Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that, in accordance with the resolutions passed at the extraordinary general meeting of shareholders held on April 22, 2025, and the resolutions adopted by the Company's board of directors on the same date, the Company has approved a reverse stock split at a consolidation ratio of one-for-ten (1-for-10). As a result, every ten ordinary shares of the Company, with a par value of US$0.01 per share (the "Shares"), issued and outstanding will automatically, and without any action required on the part of the holders, be consolidated into one validly issued, fully paid, and non-assessable Share, with no change to the par value per share (the "Reverse Stock Split").Moolec Science Logo

Moolec Science Logo

The Company anticipates that the Reverse Stock Split will take effect May 14, 2025, 8:30 AM Eastern Time (the "Effective Time") and will be reflected in the market at the start of trading, on a split-adjusted basis.

The Shares will continue to trade on the NASDAQ under the symbol "MLEC" under a new CUSIP code, which is L64875 120. The Company's publicly traded warrants will continue to be traded under the symbol "MLECW" under the same CUSIP code, which is L64875 112. As a result of the Reverse Stock Split the number of issued and outstanding Shares will be reduced from approximately 40 million Shares to approximately 4 million Shares. The Reverse Stock Split does not otherwise affect the Company's business or operations.

Registered shareholders are not required to take any action to receive Shares in connection with the Reverse Stock Split. Shareholders owning shares through an account at a brokerage firm, bank, dealer, custodian or other similar organization acting as nominee will have their positions automatically adjusted to reflect the Reverse Stock Split, subject to such broker's particular processes, and likewise will not be required to take any action in connection with the Reverse Stock Split.

Forward Looking Statements

This press release contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in Moolec's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.

Contact Information

Press & Media
comms@moolecscience.com

Investor Relations
ir@moolecscience.com

.

SOURCE: Moolec Science SA



View the original press release on ACCESS Newswire

FAQ

When will MLEC's 1-for-10 reverse stock split take effect?

Moolec Science's reverse stock split will take effect on May 14, 2025, at 8:30 AM Eastern Time and will be reflected in trading at market open.

How many shares will MLEC have after the reverse stock split?

After the 1-for-10 reverse stock split, Moolec Science's outstanding shares will be reduced from approximately 40 million to 4 million shares.

Do MLEC shareholders need to take any action for the reverse stock split?

No, shareholders do not need to take any action. Positions will be automatically adjusted to reflect the reverse stock split through their brokerage firms or custodians.

Will MLEC's stock symbol change after the reverse split?

No, Moolec Science will continue trading on NASDAQ under the symbol 'MLEC', though it will have a new CUSIP code (L64875 120).
Moolec Science

NASDAQ:MLEC

MLEC Rankings

MLEC Latest News

MLEC Stock Data

30.40M
8.76M
81.53%
0.18%
0.32%
Biotechnology
Healthcare
Link
Luxembourg
Luxembourg